Mesenchymal stem cell transplantation in newly diagnosed type 1 diabetes patients: a phase I/II randomized placebo-controlled clinical trial
Who conducted the study and which universities were involved The main work was carried out at the Royan Institute for Stem Cell Biology and Technology (ACECR), Tehran, Iran—a major Iranian center for stem cell research and regenerative medicine. Researchers from Tehran University of Medical Sciences, Iran University of Medical Sciences, and the University of Science […]
